Cargando…
Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol
BACKGROUND: Landiolol hydrochloride is a new β-adrenergic blocker with a pharmacological profile that suggests it can be administered safely to patients who have sinus tachycardia or tachyarrhythmia and who require heart rate reduction. This study aimed to investigate whether intraoperative administ...
Autores principales: | Nakanishi, Kazuhiro, Takeda, Shinhiro, Kim, Chol, Kohda, Shusuke, Sakamoto, Atsuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564867/ https://www.ncbi.nlm.nih.gov/pubmed/23347432 http://dx.doi.org/10.1186/1749-8090-8-19 |
Ejemplares similares
-
Preventive Effect of Intraoperative Landiolol Administration on Atrial Fibrillation After Off-Pump Coronary Artery Bypass Grafting
por: Osumi, Masahiro, et al.
Publicado: (2014) -
Perioperative Landiolol Administration reduces Atrial Fibrillation after Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials
por: Sakamoto, Atsuhiro, et al.
Publicado: (2014) -
Landiolol for managing atrial fibrillation in intensive care
por: Rehberg, Sebastian, et al.
Publicado: (2018) -
Landiolol for managing post-operative atrial fibrillation
por: Balik, Martin, et al.
Publicado: (2018) -
Preventive effect of low-dose landiolol on postoperative atrial fibrillation study (PELTA study)
por: Sasaki, Konosuke, et al.
Publicado: (2020)